PAA 3.03% 16.0¢ pharmaust limited

Human Trialing Commencement in 60 Days, page-3

  1. 2,645 Posts.
    lightbulb Created with Sketch. 1449
    Kpax as devils advocate on this occasion, parts of this post are interpreted by me as you having additional information that the broader market has not been made aware of.

    Im not challenging you or your character, as your input and scientific explanations have been great and welcomed.

    *Plans being instituted once a deal is iced (its close)...involves HC members as influential group.* Could you elaborate? All market knows is PAA are discussing with potential canine partners. There is no info on deal details, the timeframe, or of course HC involvement. Is this additional info you have been informed by the company of? As a t20 holder, Id certainly be interested...

    *the drug trial arm specificty on the dogs has been concluded* what does this mean? Are we not still in dosiong optimisation and propping for phase 3. Nothing else material has been released, or have I missed something?

    *three orphan drug discoveries* which are these? I know the recent tests showed in vitro effect, but I wouldn't yet claim orphan drug status? Or am I too sceptical.

    Again not trying to call out but
    1. Genuinely interested in understanding more of your views and thoughts on the above

    2. If some are in someway privy to more information (power to them) then the company needs to inform the market to level the field. Or if its personal speculation and interpretation thats cool, it just comes across as fact not opinion.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.0¢
Change
-0.005(3.03%)
Mkt cap ! $77.79M
Open High Low Value Volume
16.5¢ 17.5¢ 16.0¢ $120.8K 734.7K

Buyers (Bids)

No. Vol. Price($)
11 339247 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 135481 4
View Market Depth
Last trade - 13.08pm 08/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.